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Abstract
The current article is a statement of the meeting with international and multidisciplinary participation, held in Wrocław, Poland on
September 11–13, 2008. The meeting was devoted to working out a position focusing on the challenge for individuals, health care systems,
biological, psychosocial, epidemiological, medical, and public health sciences in the ageing populations of the twenty-first century. The
statement is presented as an overview, in tabular format, of the current European situation regarding basic biological research on ageing,
health promotion and preventive action, clinical care for older people, and recommendations for future actions.
(Pol J Endocrinol 2009; 60 (5): 408–414)
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Streszczenie
W niniejszym artykule przedstawiono ustalenia, jakie zapadły podczas Europejskiego Szczytu poświęconego chorobom związanym ze
starzeniem — European Summit — Age Related Diseases, który odbył się we Wrocławiu w dniach 11–13 września. Celem tego międzynaro-
dowego spotkania, w którym uczestniczyli specjaliści z różnych dziedzin medycyny było uzgodnienie wspólnego stanowiska na temat
indywidualnych potrzeb chorych, systemów opieki medycznej, badań biologicznych, psycho-społecznych, epidemiologicznych i doty-
czących zdrowia publicznego w aspekcie starzenia się populacji w XXI wieku. Stanowisko to przedstawiono w końcowym dokumencie
zawierającym charakterystykę obecnej sytuacji w Europie odnośnie do badań podstawowych nad biologią procesów starzenia, promocji
zdrowia i działań prewencyjnych, opieki klinicznej nad osobami w podeszłym wieku, a także zalecenia na przyszłość.
(Endokrynol Pol 2009; 60 (5): 408–414)
Słowa kluczowe: starzenie się, choroby związane z wiekiem, geriatria
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Introduction
The increase of life expectancy of the world population
is one of the highest achievements of humankind, and
Europe is leading this successful story. However, age-
ing and age-related disease are also mounting challen-
ges for individuals, for health care systems, and for bio-
logical, psychosocial, epidemiological, medical, and
public health sciences. Many scientists from every sin-
gle area of knowledge and science are actively working
to better understand ageing and to tackle the challen-
ges that it brings to twenty-first century individuals.
These challenges cannot be confronted from a sin-
gle point of view. A coordinated, active, united front of
many disciplines is needed to face them, and a strategy
that, starting from basic research, reaches every single
aspect of ageing is needed. This means that translatio-
nal research is a fundamental requirement, and that
advances coming from research should flow rapidly
through the education of professionals to the promo-
tion of healthy lifestyles, and to health and social care
meeting the needs of older people. Evidence-based li-
fespan strategies for successful ageing must be adop-
ted, with appropriate adaptation for older people to
cater for the heterogeneity and complexity of later life.
A better understanding of molecular mechanisms
of ageing, embedded in a translational matrix of geron-
tology1  and geriatric medicine, is an absolute require-
ment for the design of new clinical procedures for im-
proved prevention and management of age-associated
dysfunctions and diseases. Moreover, placing greater
stress and increasing research on public health issues
(including health promotion and protection, prevention
of disease, disability and frailty, improving quality of
life, quality of care, health care organisation, and he-
alth economy aspects) will result in better application
of results from basic and clinical research into everyday
practice (i.e. from efficacy to effectiveness). Connecting
public health research with research in other sciences
may result in translating knowledge to health policy
and strategic plans concerning older persons and their
family caregivers.
Major advances in basic ageing research have been
made possible by recent breakthroughs showing that the
mechanisms underlying ageing are conserved in evolu-
tion, so that the biology of ageing can now be studied by
looking at the causal mechanisms at work in ageing, inte-
grating approaches from senescent cells in vitro to model
systems and human studies. We now have the tools and
resources, in the form of tractable experimental systems
ranging from the sub-cellular, through animal models
(such as nematodes, insects or rodents) to humans, in or-
der to investigate the molecular mechanisms that cause
ageing. The identification of the basic mechanisms deter-
mining ageing will enable the generation of novel pro-
gnostic markers and therapeutic means to promote heal-
thy ageing and prevent age-associated disease.
Clinical and public health research has also offered
new insights about prevention and care in age related-
disease. Much is known about the prevention and tre-
atment of many acute and chronic diseases that result
in disability and impaired quality of life. However, many
European citizens are not receiving up-to-date care and
rehabilitation of these diseases, and are suffering an avo-
idable burden of suffering and disability. Older people
are not obtaining benefits from many advances in clini-
cal gerontology and in disease prevention. Public he-
alth policies addressing the specific needs of older per-
sons, and changes in the way that medical advances
are delivered to this population are needed, in order to
obtain more efficient, financially sustainable systems of
health and social care. Moreover, research is needed to
better define the role of many relevant social and eco-
nomical aspects of ageing and disease.
In our modern society, older people are frequen-
tly subject to ageism, suffering discrimination rela-
ting to the scale and scope of services they receive in
comparison to younger people. Even the terminolo-
gy used towards older people is often inappropriate,
and we concur with the proposal of the Human Ri-
ghts Commission of the United Nations in 1999 to
adapt our vocabulary, by not using the word “elder-
ly”, and using instead the term “older people”, a more
respectful approach. This change has to be adapted
to every language.
The following is a brief overview, in tabular format,
of the current European situation in basic biological re-
search on ageing, in health promotion and preventive
action, and in clinical care for older people, and the re-
commendations for future actions.
1 Gerontology, the science of ageing, is classically divided into four sub-disciplines: i) social sciences of ageing, ii) psychology of ageing, iii) biology
of ageing, and iv) clinical gerontology (within which are positioned the disciplines of geriatric medicine, old age psychiatry, and gerontological nursing,
among others). It deals with the globality of normal ageing in the first instance.
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Basic research
We know We recommend
A fundamental but poorly understood aspect of ageing is the A multidisciplinary and integrated approach is recommended,
asynchronous deterioration of organs and tissues within an in organisms ranging from simple models to humans,
individual. How the intrinsic rate of ageing within the different aiming to address the question of how ageing is modulated at
tissues is determined, how the whole body copes with this system level. The fact that the rate of ageing differs
asynchronous deterioration, and how the later diverges in old considerably between tissues is of high clinical relevance.
individuals, remains elusive. Understanding the basic molecular mechanisms responsible
for asynchronous ageing and the natural mechanisms that might
counteract these deteriorations will provide the basis for novel
diagnostic, preventive, and therapeutic strategies. This
programme could be supported through an INTEGRATIVE
PROJECT: “Call text - LSH: Asynchrony in tissue ageing”.
Intrinsic as well as external (nutrition and environment) factors Epigenetic contributions to ageing and age-related dysfunctions
regulate the progression and conditions of ageing and age-related and diseases should be studied in a comprehensive way.
disease by modulating gene expression at the epigenetic and This should be done in an integrated, multidisciplinary
posttranscriptional level. In the post-genomic era, it is becoming approach, using experimental systems ranging from simple
increasingly clear that epigenetic factors are critical determinants animal models to humans, in order to address the question of how
of ageing in diverse organisms ranging from yeast to humans. ageing is modulated by epigenetic mechanisms.
Epigenetic modulation of ageing has not been systematically Experimental   models should be developed in a way allowing
addressed so far. the translation of basic research into health care at different
levels, including preventative care, diagnosis, and therapeutics.
This knowledge would add significantly to the competitiveness
of European ageing research. This programme could be
supported through an INTEGRATIVE PROJECT: “Call text - LSH:
Epigenetic modulation of ageing processes”.
Health promotion and preventive action
We know We recommend
The altered demography of the world requires the incorporation Training of public health professionals and academics
of the principles of gerontology and geriatric medicine into those should routinely incorporate clinical gerontology as a core
of public health. component of undergraduate and postgraduate curricula.
Compliance (adherence) is a major factor limiting the Public health strategies to promote health and quality of life
effectiveness of health promotion and preventive interventions. should be based on a life course approach. They should
Older people may not respond well to interventions when they also take into account older people’s views as well as new
do not match with their beliefs, attitudes, preferences,  information from longitudinal studies on ageing, rather
expectations, and aspirations. than being paternalistic.
Strategies of successful ageing consist of having the Selection of the appropriate evidence based screening tests for
opportunity to make and making healthy lifestyle choices, older people is of great importance in order to reduce disability,
implementing various self-management techniques, being offered morbidity and mortality, and avoid unnecessary, expensive and
and taking advantage of immunisation, injury prevention, early potentially harmful diagnostic and treatment procedures.
detection interventions and correct treatment of disease.
Maintaining social network and activities is also critical to adapt Adaptations of vaccine recommendations for older adults, and
successfully to aging health challenges. different subgroups such as those living in the community and
the institutionalized oldest old are needed. The main aim should
be to promote preventive aspects in primary and secondary care,
as well as in geriatric medicine, relating to both life threatening-
diseases, and diseases that adversely impact the patient’s
independence and quality of life. Efforts should be made to
guarantee a lifelong approach to adequate vaccinations to
improve immunological response to infectious diseases.
Appropriate nutrition and nutritional care are key indicators Older persons should be encouraged to maintain good nutritional
for quality of life, disease prevention and sustainable health. habits. They should be screened for nutritional status and should
Nutritional care is not just a cost item but part of the health be proposed adequate nutritional interventions. All health and
care solution. allied care professionals should be trained in nutritional care.
European countries should consider developing national
nutritional care plans.
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Physical activity is one of the most important factors alleviating On a population/public health basis, encouraging physical
the age-related decline of biological potential and enabling activity and the provision of a range of exercise opportunities
‘successful ageing’. Maintaining independence, reducing as part of a wider campaign on prevention of falls and
morbidity, and increasing quality of life are important beneficial maintenance of independence should be popularised. Exercise
effects of physical activity in older people. recommendations should also be implemented as a secondary
Falls are more common in older people with poor balance; preventive measure in the recommendations of disease
decreased strength and mobility are important risk factors. management. The use of published evidence-based
Falls are not an inevitable consequence of ageing: there is good  recommendations for engagement of older people in preventive
evidence that progressive balance and strength interventions health care and the training of a wide range of health, social care,
reduce risk of falls amongst older people. and leisure professionals in order to meet the full range of needs,
abilities, and preferences of older people is important.
Injuries are an important cause of morbidity, disability, and Strengthening capacity building in the training of professionals
mortality among older people, impacting the quality of life and working with older people; networking of researchers,
representing an increasingly large proportion of the health practitioners and policy makers across Europe; and
expenditure. Despite the fact that almost half of the injuries are implementation of preventive programmes can significantly
now foreseeable and preventable, efforts to reduce the injury contribute to the reduction and prevention of both intentional
toll in this age group have so far been limited, inconsistent, (like suicide, abuse, violence) and unintentional (like falls,
and dispersed across different settings. traffic accidents, poisoning, and burns) injuries among
community-dwelling and institutionalised older persons. These
targets can be achieved through coordinated actions at
European, national, or local level by providing state-of-the-art
information on evidence-based practices for injury prevention
that have proven to be effective.
Mental stimulation using cognitively challenging activities is On a population/public health basis, the use of memory training,
a means to facilitate neural plasticity, which can increase mental stimulation, and mental compensation strategies,
cognitive reserve and result in maintained or improved cognitive and the training of a wide range of health professionals in order
functioning. to promote cognitive stimulation activities in older people should
be encouraged.
Social activity and social inclusion of older people is a complex Facilitating and enhancing social activity in older people is
and still under-appreciated issue with regard to successful ageing. important for society, not only in the sphere of the labour market,
Social activities include professional work, recreation, voluntary but also in other social (voluntary) initiatives, and as a preventive
activity, family life, as well as a sense of duty towards disabled measure against social exclusion. The enormous reserve of
older persons or small children. human capital offered by older people’s activity should be
recognised by policy makers and adequately supported.
To improve the quality of retirement in future generations,
the teaching of initiatives that promote social activity and
engagement should start at school, from a life course perspective.
Informal care giving has an important role in health promotion, Measures to improve public and governmental appreciation of
prevention, and care of frail, disabled, older individuals. In the the immense unpaid work performed by informal caregivers
future, demographic aging in most European countries may also should be developed (i.e. a European Caregivers’ Day). Support,
result in a substantial reduction of the number of informal training, and incentives (including financial incentives) should
caregivers available to care for disabled older persons. be offered to informal caregivers, based on the needs expressed
by themselves through their organisations, and the insights
offered by social and clinical gerontology.
Clinical care
We know We recommend
Geriatric medicine is the specialty concerned with health European countries should encourage the universal recognition
related problems in older people, including acute, chronic, and further development of geriatric medicine as a medical
and rehabilitation problems, in the community, long-stay, and specialty. An appropriate number of specialist physicians in
hospital settings. It is of proven efficacy in health promotion, geriatric medicine should be trained, certified, and incorporated
health gain, health maintenance, and palliative care for older into national health systems. Old age psychiatry should also be
people. Geriatric medicine is an independent medical specialty developed.
in the majority of European countries, but not in all, although There is clear need for specialist training across all heath and
the number of older patients and the complexity of their medical social care professions (including nursing, social work,
conditions are growing fast. Old age psychiatry is also largely physiotherapy, occupational therapy, clinical psychology,
underdeveloped in most European countries, while some mental and public health practitioners) to meet the challenges
health diseases have a growing prevalence and impact on the of successful ageing.
quality of life of older individuals. Specialist gerontological nursing
is an enormously important means of ensuring better care of
older people within the healthcare system.
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The use of drugs in older people is complex. Age related changes A Geriatric Medicine Committee should be established within
in pharmacokinetics and pharmacodynamics, polypharmacy, the European Medicines Agency (EMEA) to improve research
multiple comorbid diseases, and drug-drug, as well as on every aspect of drug use in older people, to improve the
drug-disease interactions all increase the number and severity appropriateness of drug treatments in complex situations,
of adverse drug reactions (ADR). Moreover, non-adherence and to reduce patient risk.
to treatment may limit the success of any therapy. Many hospital
admissions are due to ADR in this population. Discrimination
against older people by their exclusion from clinical drug trials
limits the body of evidence on which therapeutic decisions can be
correctly made. In many cases, evidence-based, life-saving
therapies are not offered to older individuals.
Multifactorial interventions led by geriatricians Multidimensional comprehensive geriatric assessment
(i.e. hospital acute geriatric assessment units, models should be made available to every older person, and fitted to
of integrated care, old age psychiatry, rehabilitation, home care) each individual’s profile. A comprehensive management plan
have been shown to result in better patient outcomes (such as should be elaborated, implemented, and periodically reviewed.
lower disability and mortality, reduced need for long term care, The objective is not only to restore health, but also to restore and
etc) at a similar or lower cost than usual care. maintain the highest possible level of independence and physical
and mental autonomy. Interventions that have been clearly
shown to improve health outcomes should be offered to affected
older people. Outcomes should be adapted to the needs of each
individual, who may prefer autonomy to longevity.
Services for health care for older persons are heterogeneous, In the very near future, older patients admitted to hospitals in
and the availability of acute care, rehabilitation, long-term care, the European Union should have access to specialist geriatric
palliative care, old age psychiatry, home care, and nursing homes care, which will offer coordinated and integrated multidisciplinary
differs greatly not only between European countries, but even care, adapted to the needs of each individual, their families,
within most of them. Often, these services do not incorporate the and caregivers. In case of illness, frail and complex older people
fundamentals of modern clinical gerontology. This is a breach of in Europe should have access to treatment provided by
the UN Convention of Human Rights, which mandates the right geriatricians and their teams. Technological aids have to be
to the highest achievable standard of health care. The right of an gradually incorporated in all aspects of care of older people.
older European citizen to receive comprehensive, up-to-date Each European country should develop a full spectrum of high
geriatric medical and social care currently depends greatly  quality services for older people, which includes health care
on his/her place of residence. (both in- and out-patient, acute, and chronic), home care, and
care homes, and make them financially sustainable, available,
and accessible to all those in need.
Care for specific groups of older patients is also extremely Palliative and end-of-life care, informed by evidence and the
heterogeneous between and within European countries. principles of clinical gerontology and geriatric medicine should be
made available for older individuals who have diseases in their
late and final stages, at the moment they need it. Palliative
medicine should not be targeted to cancer patients only.
Old age psychiatry should also be developed to address
adequately in the future the large share of mental health
problems that affect older persons (dementia, delirium, etc).
Long-term care for older people is an under-funded and Older people should receive a comprehensive assessment to
under-resourced area of practice in most European countries. determine the need for long-term care and the possibility of
Many individuals do not get a comprehensive assessment to recovering enough function to live in a less complex environment.
determine their therapeutic and rehabilitation potential, frequently This needs assessment that should lead to appropriate
resulting in a failure to recognise the complexity of health and investigation, treatment and support, using a bio-psycho-socio-
social care needs. A huge amount of care rests on family -spiritual model informed by modern clinical gerontology and
members who bear the costs and responsibility, usually for long geriatric medicine principles. Long-term care professionals
periods of time. should be trained in the effective use of validated comprehensive
assessment tools and individual care plans for residents.
A quality of care assurance system should be implemented
in long-term care facilities to protect older people against
discrimination, marginalisation, and malpractice. Informal
caregivers should be supported emotionally, socially, financially,
and with technological innovations, and should have access
to support services.
A big share of health care of older patients depends on general Medical schools should have academic departments of
practitioners /family physicians, and on monospecialists. geriatric medicine to provide leadership in undergraduate and
However, most of these physicians receive very little, if any, postgraduate training and research. Every student of medical,
teaching on the multiple aspects of care of older people. nursing, or allied health professions (physio-occupational and
other therapies, social work, etc) should receive teaching and
should be trained in old age medicine and psychiatry, and this
should become a mandatory part of the academic curriculum
and post-graduate training of all health care professionals.
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Health services research rarely includes frail older individuals. Research in the prevention and treatment of disabling and
Research outcomes that are relevant for younger populations chronic disorders should: a) include the full spectrum of people
(i.e. mortality) may lose importance at advanced age. Health who are likely to benefit from it (including frail, older people,
service research is limited, and the impact of changes in the taking into account gender differences in ageing), b) use relevant
organization and delivery of health services regarding the function outcomes, which include not only mortality, but also disability,
and health of older people is rarely considered. use of health care and community services, quality of care, and
quality of life, c) be informed by evidence and the principles
of modern clinical gerontology and geriatric medicine, and
d) include public health issues. There is also an obvious and
continuing need for research in the way that health services
have to adapt to meet the new challenges brought about by
changes in demography, diseases, demands, disability, and
social support.
Research in old age health and disease is fragmented, with A European Institute of Ageing would be an excellent answer,
limited interactions between basic, epidemiological, preventive, able to improve basic, translational, and applied research in the
clinical, and health service research. Translational research is ageing process, and in the prevention, treatment, and
particularly sparse, despite evidence of the difficulties to translate rehabilitation of diseases of older people. It would bring
demonstration projects into routine health care delivery. awareness, funds, leadership, and coordination. In view of our,
Ineffective treatment strategies are wasteful of ever-scarcer as yet, limited understanding of the benefits and challenges
resources. of an ageing Europe. It would also contribute to the vision
of the Lisbon declaration that Europe would have the most
competitive knowledge-based economy in the world by 2010.
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